Abstract
Parasitic diseases affect a number of people all over the world, especially in underdeveloped countries. Leishmaniasis affects around 2 million people a year, and approximately 350 million people are at risk worldwide. The current drugs used in the treatment of this parasite are not ideal, requiring less toxic and less expensive therapies. The antileishmanial compounds derived from furoxa…